Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium HandiHaler versus Combivent MDI in COPD patients previously prescribed Combivent
2006-000822-30Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2006
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Tiotropium HandiHaler with Combivent MDI (2 arms). Primary endpoints: Trough FEV1 after 12 weeks and FEV1 AUC0-6 hours after 12 weeks. Started Aug 2006; status: completed.
02
Drugs
tiotropiumCombivent
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2006-000822-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000822-30.